Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 4:4:179.
doi: 10.3389/fmed.2017.00179. eCollection 2017.

New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology

Philippe Musette  1 , Baptiste Janela  2
Affiliations
Review

New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology

Philippe Musette et al. Front Med (Lausanne). .

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome, is a severe type of cutaneous drug-induced eruption. DRESS may be a difficult disease to diagnose since the symptoms mimic those of cutaneous and systemic infectious pathologies and can appear up to 3 months after the initial culprit drug exposure. The symptoms of DRESS syndrome include rash development after a minimum of 3 weeks after the onset of a new medication, associated with facial edema, lymphadenopathy, and fever. Biological findings include liver abnormalities, leukocytosis, eosinophilia, atypical lymphocytosis, and reactivation of certain human herpes viruses. In DRESS, liver, kidneys, and lungs are frequently involved in disease evolution. Patients with serious systemic involvement are treated with oral corticosteroids, and full recovery is achieved in the majority of cases. DRESS is a rare disease, and little is known about factors that predict its occurrence. The key features of this reaction are eosinophil involvement, the role of the culprit drug, and virus reactivation that trigger an inappropriate systemic immune response in DRESS patients. Interestingly, it was evidenced that at-risk individuals within a genetically restricted population shared a particular HLA loci. In this respect, a limited number of well-known drugs were able to induce DRESS. This review describes the up-to-date advances in our understanding of the pathogenesis of DRESS.

Keywords: cytokines; drug-induced eruption; eosinophil; side effects; virus replication.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunological mechanism involved in drug reaction with eosinophilia and systemic symptoms.
Figure 2
Figure 2
Role of eosinophils in drug reaction with eosinophilia and systemic symptoms.
See this image and copyright information in PMC

References

    1. Schrijvers R, Gilissen L, Chiriac AM, Demoly P. Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back. Clin Transl Allergy (2015) 5:31.10.1186/s13601-015-0073-8 - DOI - PMC - PubMed
    1. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol (2007) 156(3):609–11.10.1111/j.1365-2133.2006.07704.x - DOI - PubMed
    1. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol (2007) 156(5):1083–4.10.1111/j.1365-2133.2007.07807.x - DOI - PubMed
    1. Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: a literature review. Am J Med (2011) 124(7):588–97.10.1016/j.amjmed.2011.01.017 - DOI - PubMed
    1. Gerber BO, Pichler WJ. Cellular mechanisms of T cell mediated drug hypersensitivity. Curr Opin Immunol (2004) 16(6):732–7.10.1016/j.coi.2004.09.016 - DOI - PubMed